BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 29668749)

  • 1. p73, like its p53 homolog, shows preference for inverted repeats forming cruciforms.
    Čechová J; Coufal J; Jagelská EB; Fojta M; Brázda V
    PLoS One; 2018; 13(4):e0195835. PubMed ID: 29668749
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The structure formed by inverted repeats in p53 response elements determines the transactivation activity of p53 protein.
    Brázda V; Čechová J; Battistin M; Coufal J; Jagelská EB; Raimondi I; Inga A
    Biochem Biophys Res Commun; 2017 Jan; 483(1):516-521. PubMed ID: 28007599
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of the Activity in the p53 Family Depends on the Organization of the Transactivation Domain.
    Krauskopf K; Gebel J; Kazemi S; Tuppi M; Löhr F; Schäfer B; Koch J; Güntert P; Dötsch V; Kehrloesser S
    Structure; 2018 Aug; 26(8):1091-1100.e4. PubMed ID: 30099987
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deciphering the mechanism of p73 recognition of p53 response elements using the crystal structure of p73-DNA complexes and computational studies.
    Koley T; Chowdhury SR; Kushwaha T; Kumar M; Inampudi KK; Kaur P; Singh TP; Viadiu H; Ethayathulla AS
    Int J Biol Macromol; 2022 May; 206():40-50. PubMed ID: 35217090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Backbone resonance assignments of the human p73 DNA binding domain.
    Cino EA; Soares IN; Freitas MS; Silva JL
    Biomol NMR Assign; 2016 Apr; 10(1):49-51. PubMed ID: 26294377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutant and wild-type p53 form complexes with p73 upon phosphorylation by the kinase JNK.
    Wolf ER; McAtarsney CP; Bredhold KE; Kline AM; Mayo LD
    Sci Signal; 2018 Apr; 11(524):. PubMed ID: 29615516
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ∆Np73 is capable of inducing apoptosis by co-ordinately activating several BH3-only proteins.
    Sánchez-Carrera D; García-Puga M; Yáñez L; Romón Í; Pipaón C
    Biosci Rep; 2015 Apr; 35(3):. PubMed ID: 26182360
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synergistic activation of the NEU4 promoter by p73 and AP2 in colon cancer cells.
    Cai BH; Wu PH; Chou CK; Huang HC; Chao CC; Chung HY; Lee HY; Chen JY; Kannagi R
    Sci Rep; 2019 Jan; 9(1):950. PubMed ID: 30700826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Crystal structures of the DNA-binding domain tetramer of the p53 tumor suppressor family member p73 bound to different full-site response elements.
    Ethayathulla AS; Nguyen HT; Viadiu H
    J Biol Chem; 2013 Feb; 288(7):4744-54. PubMed ID: 23243311
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preferential binding of p53 tumor suppressor to p21 promoter sites that contain inverted repeats capable of forming cruciform structure.
    Coufal J; Jagelská EB; Liao JC; Brázda V
    Biochem Biophys Res Commun; 2013 Nov; 441(1):83-8. PubMed ID: 24134839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA modification with cisplatin affects sequence-specific DNA binding of p53 and p73 proteins in a target site-dependent manner.
    Pivonková H; Pecinka P; Cesková P; Fojta M
    FEBS J; 2006 Oct; 273(20):4693-706. PubMed ID: 16981908
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure of p73 DNA-binding domain tetramer modulates p73 transactivation.
    Ethayathulla AS; Tse PW; Monti P; Nguyen S; Inga A; Fronza G; Viadiu H
    Proc Natl Acad Sci U S A; 2012 Apr; 109(16):6066-71. PubMed ID: 22474346
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA topology influences p53 sequence-specific DNA binding through structural transitions within the target sites.
    Jagelská EB; Brázda V; Pecinka P; Palecek E; Fojta M
    Biochem J; 2008 May; 412(1):57-63. PubMed ID: 18271758
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluating the Influence of a G-Quadruplex Prone Sequence on the Transactivation Potential by Wild-Type and/or Mutant P53 Family Proteins through a Yeast-Based Functional Assay.
    Monti P; Brazda V; Bohálová N; Porubiaková O; Menichini P; Speciale A; Bocciardi R; Inga A; Fronza G
    Genes (Basel); 2021 Feb; 12(2):. PubMed ID: 33672023
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intrinsic aggregation propensity of the p63 and p73 TI domains correlates with p53R175H interaction and suggests further significance of aggregation events in the p53 family.
    Kehrloesser S; Osterburg C; Tuppi M; Schäfer B; Vousden KH; Dötsch V
    Cell Death Differ; 2016 Dec; 23(12):1952-1960. PubMed ID: 27447112
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Curcumin induces apoptosis in p53-null Hep3B cells through a TAp73/DNp73-dependent pathway.
    Wang J; Xie H; Gao F; Zhao T; Yang H; Kang B
    Tumour Biol; 2016 Mar; 37(3):4203-12. PubMed ID: 26490992
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p73 coordinates with Δ133p53 to promote DNA double-strand break repair.
    Gong H; Zhang Y; Jiang K; Ye S; Chen S; Zhang Q; Peng J; Chen J
    Cell Death Differ; 2018 Jun; 25(6):1063-1079. PubMed ID: 29511339
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p73: From the p53 shadow to a major pharmacological target in anticancer therapy.
    Ramos H; Raimundo L; Saraiva L
    Pharmacol Res; 2020 Dec; 162():105245. PubMed ID: 33069756
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The dominant-negative interplay between p53, p63 and p73: A family affair.
    Billant O; Léon A; Le Guellec S; Friocourt G; Blondel M; Voisset C
    Oncotarget; 2016 Oct; 7(43):69549-69564. PubMed ID: 27589690
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transcription factor p73 regulates Th1 differentiation.
    Ren M; Kazemian M; Zheng M; He J; Li P; Oh J; Liao W; Li J; Rajaseelan J; Kelsall BL; Peltz G; Leonard WJ
    Nat Commun; 2020 Mar; 11(1):1475. PubMed ID: 32193462
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.